# Infinite Intelligent Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/infinite-intelligent-pharma

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.iipharma.com
- Latest round: Angel (Jul 19, 2019)
- Investors on record: 2

## About

Founded in 2018 and based in Beijing, China, Infinite Intelligent Pharma operates as a pharmaceutical company that focuses on the research and development of drugs based on artificial intelligence technology. It was recognized as the National High-tech Enterprise. Jianfeng Pei, the company's founder, graduated from the Institute of Process Engineering, Chinese Academy of Sciences, and is a researcher at the Center for Quantitative Biology, Peking University. In February 2021, Infinite Intelligent Pharma closed a pre-series A funding from new investor Livzon Pharmaceutical Group Inc. The company set up a branch office in Suzhou in 2021.

The company's main business is the research and development of innovative drugs using artificial intelligence. Products include PharmaMind, a molecular design evaluation computing platform, TopTargets, a target discovery computing platform, and the AI plus new drug development platform, Smart Drug BrainTM. Smart Drug Brain is a drug discovery system that integrates experts and drug design methods. The company also provides technical services and intellectual property solutions for pharmaceutical companies.

The company generates revenue by providing AI drug development platforms and related services.

## Funding rounds

- Angel, Jul 19, 2019 — WI Harper Group, Casstar Capital

## Investors

- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Angel
- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Angel